Savara (NASDAQ:SVRA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Savara (SVRA) operate in?

Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Savara Stock (NASDAQ: SVRA) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	22.00 / 1.73M
Day Range	- - -
52 Wk Range	3.12 - 5.70
Market Cap	$746.54M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	6.32%
Days to Cover	1.6

Recent News

Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday?

Savara announces Phase 3 IMPALA-2 trial results for molgramostim in treating autoimmune pulmonary alveolar proteinosis. The inhaled GM-CSF met primary and secondary endpoints, showing significant improvements.

Vandana Singh

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Avi Kapoor

5 OTC Stocks With The Potential To Explode In 2024

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.

Chris Bibey

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Savara Inc

Sector

Health Care

Industry

Biotechnology

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Savara (SVRA) stock?

You can purchase shares of Savara (NASDAQ:SVRA) through any online brokerage.

View our list of the best stock brokerages

Who are Savara (SVRA) competitors?

Other companies in Savara’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB), KalVista Pharma (NASDAQ:KALV) and 4D Molecular Therapeutics (NASDAQ:FDMT).

What is the target price for Savara (SVRA) stock?

There is no analysis for Savara.

What is the forecast for Savara (SVRA) stock?

Savara has a consensus price target of $9.71.

Current stock price for Savara (SVRA)?

The stock price for Savara (NASDAQ: SVRA) is $4.54 last updated July 19, 2024 at 6:54 PM EDT.

Does Savara (SVRA) pay a dividend?

There are no upcoming dividends for Savara.

When is Savara (NASDAQ:SVRA) reporting earnings?

Savara’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Savara (SVRA) going to split?

There is no upcoming split for Savara.

What sector and industry does Savara (SVRA) operate in?

Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Savara

Savara (SVRA) Forecast